Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders

Cancer Genetics and Cytogenetics

Volumn 191, Issue 1, 2009, Pages 10-16

  Tu, Zheng ^a   Zhang, Aipeng ^b   Wu, Ruifang ^c   Jiang, Jing ^a   Li, Yali ^b   Wulan, Na ^c   Li, Jingran ^a   Zhang, Yongmei ^b   Li, Yibing ^c   Chen, Zhong ^d,e   Wei, Lihui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b General Hospital of the People's Liberation Army   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^d ARUP LABORATORIES   (United States)

^e China Medical Board   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE;

ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERUS BIOPSY; WART VIRUS;

DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE AMPLIFICATION; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PAPILLOMAVIRIDAE; RNA; TELOMERASE; UTERINE CERVICAL DISEASES;

HUMAN PAPILLOMAVIRUS;

EID: 64749109630     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.01.004     Document Type: Article

References (35)

1. World Health Organization Reproductive Health and Research, Chronic Diseases and Health Promotion. Comprehensive cervical cancer control: a guide to essential practice (2006), World Health Organization, Geneva
2. Koopman L.A., Szuhai K., van Eendenburg J.D., Bezrookove V., Kenter G.G., Schuuring E., Tanke H., and Fleuren G.J. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer research 59 (1999) 5615-5624
3. Hopman A.H., Theelen W., Hommelberg P.P., Kamps M.A., Herrington C.S., Morrison L.E., Speel E.J., Smedts F., and Ramaekers F.C. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. The Journal of pathology 210 (2006) 412-419
4. Glanz C., Rebetz J., Stewénius Y., Persson A., Englund E., Mandahl N., Mertens F., Salford L.G., Widegren B., Fan X., and Gisselsson D. Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability. Neuropathol Appl Neurobiol 33 (2007) 440-454
5. Zhang H., Jin Y., Chen X., Jin C., Law S., Tsao S.W., and Kwong Y.L. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. Cancer Lett 245 (2007) 184-194
6. Palmqvist R., Zhang A., Xu D., Golovleva I., Norrback K.F., Gruber A., Oberg A., Stenling R., and Roos G. hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer. Int J Cancer 116 (2005) 395-400
7. Pelosi G., Del Curto B., Trubia M., Nicholson A.G., Manzotti M., Veronesi G., Spaggiari L., Maisonneuve P., Pasini F., Terzi A., Iannucci A., and Viale G. 3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res 13 (2007) 1995-2004
8. Hashimoto Y., Murakami Y., Uemura K., Hayashidani Y., Sudo T., Ohge H., Fukuda E., Shimamoto F., Sueda T., and Hiyama E. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas. J Gastrointest Surg 12 (2008) 17-28 discussion 28-9
9. Forsyth R.G., De Boeck G., Bekaert S., De Meyer T., Taminiau A.H., Uyttendaele D., Roels H., Praet M.M., and Hogendoorn P.C. Telomere biology in giant cell tumour of bone. J Pathol 214 (2008) 555-563
10. Wang R., Lin F., Wang X., Gao P., Dong K., Wei S.H., Cheng S.Y., and Zhang H.Z. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Cancer Biol Ther 6 (2007) 1295-1301
11. Zhang A., Wang J., Zheng B., Fang X., Angström T., Liu C., Li X., Erlandsson F., Björkholm M., Nordenskjörd M., Gruber A., Wallin K.L., and Xu D. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 23 (2004) 7441-7447
12. Wisman G.B., De Jong S., Meersma G.J., Helder M.N., Hollema H., de Vries E.G., Keith W.N., and van der Zee A.G. Telomerase in (pre)neoplastic cervical disease. Hum Pathol 31 (2000) 1304-1312
13. Zheng P.S., Iwasaka T., Yokoyama M., Nakao Y., Pater A., and Sugimori H. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol 66 (1997) 222-226
14. Branca M., Giorgi C., Ciotti M., Santini D., Di Bonito L., Costa S., Benedetto A., Bonifacio D., Di Bonito P., Paba P., Accardi L., Mariani L., Ruutu M., Syrjänen S., Favalli C., and Syrjänen K. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagnostic cytopathology 34 (2006) 739-748
15. Wang P.H., Chen G.D., Chang H., Yang S.F., Han C.P., Lin L.Y., and Ko J.L. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection. Reprod Sci 14 (2007) 338-348
16. Hsu C.G., Wang P.H., Ko J.L., Chen G.D., Chang H., Yang S.F., Chen S.C., and Lin L.Y. Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer 17 (2007) 851-857
17. Ault K.A., Allen H.K., Phillips S.L., Zimmerman M.B., and Klingelhutz A.J. Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears. J Low Genit Tract Dis 9 (2005) 93-99
18. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright Jr. T., Young N., and Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
19. Li J., Wei L., Liu N., Zhao L., Wei P., Zhao C., Cui S., Tu Z., Zhao Y., and Chen Z. Evaluation of sampling and processing procedures for FISH analysis of cytological specimens of the cervix. Chin Gynecol Obstet Clin 8 (2007) 435
20. Caraway N.P., Khanna A., Dawlett M., Guo M., Guo N., Lin E., and Katz R.L. Gain of the 3q26 region in cervicovaginal liquid-based Pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 110 (2008) 37-42
21. Heselmeyer-Haddad K., Sommerfeld K., White N.M., Chaudhri N., Morrison L.E., Palanisamy N., Wang Z.Y., Auer G., Steinberg W., and Ried T. Genomic amplification of the human telomerase gene (TERC) in Pap smears predicts the development of cervical cancer. Am J Pathol 166 (2005) 1229-1238
22. de Wilde J., Wilting S.M., Meijer C.J., van de Wiel M.A., Ylstra B., Snijders P.J., and Steenbergen R.D. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer. Int J Cancer 122 (2008) 877-888
23. Andersson S., Wallin K.L., Hellström A.C., Morrison L.E., Hjerpe A., Auer G., Ried T., Larsson C., and Heselmeyer-Haddad K. Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95 (2006) 331-338
24. Ferber M.J., Montoya D.P., Yu C., Aderca I., McGee A., Thorland E.C., Nagorney D.M., Gostout B.S., Burgart L.J., Boix L., Bruix J., McMahon B.J., Cheung T.H., Chung T.K., Wong Y.F., Smith D.I., and Roberts L.R. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 22 (2003) 3813-3820
25. Kailash U., Soundararajan C.C., Lakshmy R., Arora R., Vivekanandhan S., and Das B.C. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 95 (2006) 1250-1257
26. Oikonomou P., Messinis I., and Tsezou A. DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions. Exp Biol Med (Maywood) 232 (2007) 881-886
27. Nair P., Jayaprakash P.G., Nair M.K., and Pillai M.R. Telomerase, p53 and human papillomavirus infection in the uterine cervix. Acta Oncol 39 (2000) 65-70
28. Riethdorf S., Riethdorf L., Schulz G., Ikenberg H., Jänicke F., Löning T., and Park T.W. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol 20 (2001) 177-185
29. Olaharski A.J., Sotelo R., Solorza-Luna G., Gonsebatt M.E., Guzman P., Mohar A., and Eastmond D.A. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27 (2006) 337-343
30. Sharma A., Rajappa M., Saxena A., and Sharma M. Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer. Mol Diagn Ther 11 (2007) 193-201
31. Tsezou A., Oikonomou P., Kollia P., Mademtzis I., Kostopoulou E., Messinis I., and Vamvakopoulos N. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias. Exp Biol Med (Maywood) 230 (2005) 263-270
32. Oikonomou P., Mademtzis I., Messinis I., and Tsezou A. Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load. Hum Pathol 37 (2006) 135-142
33. Wisman G.B., Hollema H., de Jong S., ter Schegget J., Tjong-A-Hung S.P., Ruiters M.H., Krans M., de Vries E.G., and van der Zee A.G. Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear. J Clin Oncol 16 (1998) 2238-2245
34. Jarboe E.A., Thompson L.C., Heinz D., McGregor J.A., and Shroyer K.R. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol 35 (2004) 396-402
35. Ngan H.Y., Cheung A.N., Liu S.S., Liu K.L., and Tsao S.W. Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening. Tumour Biol 23 (2002) 87-92